Literature DB >> 2027136

Chronic inflammatory joint diseases: natural inhibitors of interleukin 1 and tumor necrosis factor alpha.

J M Dayer1.   

Abstract

Cytokines play a major role in the initiation of the immune response or acute inflammatory events, and in the transition to or persistence of chronic inflammation, which eventually lead to tissue destruction and/or fibrosis. Cytokine inhibitors, peptides, have been recently isolated from normal or pathological biological fluids and cell culture supernatants. They can impede either acute inflammation or the transition to chronic inflammation. Two well defined molecules have been identified, interleukin 1 inhibitor, and tumor necrosis factor alpha inhibitor. They may be part of an attempt to control the expansion of the inflammation. The balance between cytokines and their inhibitors is of importance in the control of inflammatory diseases, and the lack of natural cytokine inhibitors may play a major part in maintaining inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2027136

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  6 in total

Review 1.  Patellar tendinopathy: some aspects of basic science and clinical management.

Authors:  K M Khan; N Maffulli; B D Coleman; J L Cook; J E Taunton
Journal:  Br J Sports Med       Date:  1998-12       Impact factor: 13.800

2.  Detection of tumour necrosis factor alpha and interleukin-1 beta in the rheumatoid osteoarthritic cartilage-pannus junction by immunohistochemical methods.

Authors:  V E Miller; K Rogers; K D Muirden
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

3.  Early induction of IL-1 receptor antagonist (IL-1Ra) in infants and children undergoing surgery.

Authors:  E M O Nualláin; P Puri; D J Reen
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

4.  Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor alpha by human monocytes.

Authors:  A Herbelin; E Ruuth; D Delorme; C Michel-Herbelin; F Praz
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

5.  A novel cis-acting element required for lipopolysaccharide-induced transcription of the murine interleukin-1 beta gene.

Authors:  S A Godambe; D D Chaplin; T Takova; L M Read; C J Bellone
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

Review 6.  New options in the management of tendinopathy.

Authors:  Nicola Maffulli; Umile Giuseppe Longo; Mattia Loppini; Filippo Spiezia; Vincenzo Denaro
Journal:  Open Access J Sports Med       Date:  2010-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.